<DOC>
	<DOCNO>NCT02526394</DOCNO>
	<brief_summary>The trial include group receive various combination meningitis C pertussis contain vaccine , administer concomitantly adolescent due school leave booster vaccination ( per UK routine immunisation schedule 13-17 year age ) . Immunogenicity reactogenicity assess .</brief_summary>
	<brief_title>Pertussis Meningitis C Concomitant Vaccination Adolescents</brief_title>
	<detailed_description>Recent number case infection meningococcal C pertussis ( whooping cough ) , characteristic people case , make clear UK adolescent require booster dos vaccination near future . These increasingly important priority national immunisation policy adviser Department Health , Joint Committee Vaccination Immunisation ( JCVI ) . There good indication likely target agegroup booster vaccination 14-17 year . Therefore study seek primarily measure antibody responses meningitis C whoop cough vaccine give time agegroup , see well vaccine tolerate . Up 800 adolescent recruit across eight study group . The eight group arise result combination four meningococcal two whooping cough vaccine participant receive single dose two type vaccine ( i.e . two injection ) . Two blood sample collect 10ml , one prior vaccination second 35 week later . These sample allow assessment immune system respond vaccination term antibody present blood . The study also assess well vaccine tolerate age group give together , describe . Each participant therefor ask complete health diary week follow vaccination . This record redness/ swelling/ pain injection site well illnesses visit GP hospital .</detailed_description>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Participant willing able give write informed consent participation . If age 16 year , parent/legal guardian give consent participant give write assent participation study . Male female age 13 year 6 month ( +0 day ) 17 year ( +364 day ) day consent . Completed childhood meningococcal serogroup C pertussis vaccination accord UK ( catchup and/or routine ) schedule appropriate participant 's age The participant may enter study ANY follow apply : Any contraindication vaccination specify `` Green Book '' Immunisation Infectious Disease . Significant illness include progressive neurological disease seizure disorder ; confirm suspect immunosuppressive immunodeficient condition ; major congenital defect ; know bleed diathesis ( condition may associate prolonged bleeding time ) . Any significant condition circumstance , opinion investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study . History invasive meningococcal disease pertussis . Significant contact ( household intimate exposure ) individual culture prove Neisseria meningitis disease pertussis previous 60 day . Received routine teenage booster dose tetanus/diphtheria/polio Pregnancy Temporary Exclusion Criteria Fever ( sublingual temperature ≥ 38°C ) Received systemic antibiotic ( ) ( either oral parenteral ) within past 7 day . For visit , allow study visit window , receipt systemic antibiotic ( either oral parenteral ) delay venepuncture least 7 day cessation antibiotic . Received blood blood product within past 12 week . Received another investigational agent within 90 day completion safety followup period another study , whichever longer , prior enrollment unwilling refuse participation another investigational trial end study . Possibility pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>